Medical Fluid Bag Market

The global medical fluid bags market was valued at $ 3,531.80 million in 2020 and is projected to reach $ 6,057.60 million by 2030 registering a CAGR of 5.50% from 2021 to 2030.Medical fluid bags are used in fluid replacement therapy to ensure correct body fluid collection, electrolyte imbalances, blood transfusions, and oral or enteral patient nutrition. These bags are typically composed of different polymers and include pockets for storing body fluids in a variety of biomedical procedures. 

Medical fluid bags are available in variable sizes and comprise an inner pouch and external plastic coating. The compartmentalization of these bags into an inner pouch and outer coating helps to protect the fluids until the proposed expiration date listed on the bags. These bags are widely used in healthcare settings with a multipurpose approach to maintain adequate sterilized conditions for the blood samples that help in ensuring infection-free premises, reducing disease spread, and preventing any loss of blood samples or medicines. Furthermore, these bags are also used in fluid replacement therapy that is performed to ensure adequate body fluid collection, blood transfusions, electrolyte imbalances, and maintenance of healthy nutritional intake of the patient through an oral or enteral route of administration.

The rise in incidences of different chronic conditions such as diabetes, cancer, cardiovascular diseases, kidney and liver infections, is among the key drivers propelling the growth of the medical fluid bags market globally. Furthermore, the rising prevalence of gastrointestinal disease particularly among the elderly population will drive the industry growth. Complications associated with the use of PVC-composed medical fluid bags on patient health and concerns regarding improper disposal causing a detrimental impact on the environment may impact the market growth. Conversely, the expansion of the hospital and healthcare sector globally has significantly boosted the use of intravenous fluid bags.

The COVID-19 pandemic influenced the medical fluid bags market in the initial phase. The coronavirus outbreak had a large economic impact, inflicting significant loss and increasing disease burden across many countries. Several sectors have experienced the drastic impact of the outbreak resulting in financial adversities with the healthcare sector at the forefront. Factors such as supply chain disturbances and raw material shipment delays, have affected the industry growth.

Furthermore, in March 2020, WHO issued interim guidelines that suggest providing intravenous fluid treatment for infected and critical COVID-19 patients. The UK Joint Anesthetic and Intensive Care & International Fluid Academy also advised giving critical patients fluid therapy to meet their fluid and electrolyte requirements. Such guidelines will increase the demand for intravenous bags used in IV therapy, resulting in increased revenue for the medical fluid bags market. Furthermore, the European Society for Clinical Nutrition and Metabolism (ESPEN) is recommending for the use of enteral and parenteral nutrition to meet the daily nutritional requirements of the COVID-19 patients. The cancellation of elective surgeries, allotment of a significant percentage of healthcare resources dedicated for COVID-19 have resulted in a decline in overall admissions, thereby hampering the industry demand to some extent.

Medical Fluid Bags Market Segmentation  

The global medical fluid bags market segmented on the basis of product type, material, end user and region. On the basis of product type, it is further classified into blood bags, intravenous bags, drain bags, dialysis bags and others. By material, it is divided into PVC compounds, polyolefins and others. Based on end user, it is categorized into hospitals, blood banks and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA

Segment Review

The PVC (polyvinyl chloride) compounds segment dominated the global market by material type in 2020 and is expected to continue this trend throughout the forecast period. PVC (polyvinyl chloride) medical bags are lightweight, steam sterilization, and more significantly affordable in comparison to other choices. These bags are highly preferred for collection and storage of blood & blood components because they have a 42 days of shelf life that is crucial for the storage of rare blood types. PVC (polyvinyl chloride) blood bags allows the most stringent sterilization techniques and allow freezing if required. Moreover, two of the PVCMed Alliance member companies have developed phthalate DEHP-free PVC (Polyvinyl chloride) blood bags that meet the high standard requirements for blood collection & storage. The development of DEHP (di2-ethylhexyl phthalate)-free medical bags will enhance the acceptance rate of PVC medical bags.

Depending on the end-user, the hospital segment exhibited the highest growth in 2020. Fluid bags are now widely used for separate blood components such as plasma and platelets to treat various infections and diseases. Furthermore, the growth of the hospital and healthcare sector throughout the globe has tremendously increased the use of medical fluid bags. This is anticipated to provide significant future opportunities during the forecast period.

Snapshot of the Asia-Pacific Medical Fluid Bag Market  

The U.S. dominated the North American medical fluid bags market because of the rising hospital visits and growing surgical volume across the country. According to the Healthcare Cost and Utilization Project statistics, approximately 17.2 million hospital visits were reported in ambulatory surgical centers as well as hospitals for invasive and therapeutic surgeries across the U.S. According to data from the National Center for Health Statistics, around 48 million inpatient surgeries were carried out in the U.S. The increasing number of surgical procedures will benefit the medical fluid bags as these bags form an integral part of surgical essentials and are used in draining bodily fluids, providing liquid medications, nutrition, electrolytes, and blood to the patient.

The key market players profiled in the report include Amsino International Inc., B. Braun Medical, Baxter International, ConvaTec, Fresenius Kabi, Hospira Inc., Pall Corporation, Smiths Medical, Terumo, Thermo Fisher Scientific Inc. and Westfield Medical Ltd.

Key Benefits For Stakeholders

• The study provides an in-depth analysis of the global medical fluid bags market along with the current trends and future estimations to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to influence the market opportunities.
• Extensive analysis of the key segments of the industry helps understand the product types of medical fluid bags used across the globe.
• Key market players and their strategies are analyzed to understand the competitive outlook of the market.

Key Market Segments

By Product Type

• Blood Bags
• Intravenous Bags
• Drain Bags
• Dialysis Bags
• Others

By Material

• PVC Compounds
• Polyolefins
• Others

By End user

• Hospitals    
• Blood Banks    
• Others 

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China 
  • Australia
  • India
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

 Medical Fluid Bag Market Report Highlights